The European Union approved an expanded use of Cialis, produced by Indianapolis-based Eli Lilly Co.(Photo: Michael Conroy, AP)
INDIANAPOLIS -- The European Union has approved Eli Lilly and
Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an
Lilly, based in Indianapolis, said Tuesday the
commission approved a 5-milligram, once-daily dose to treat the signs
and symptoms of the condition also known as benign prostatic
Those symptoms include the need to urinate frequently
or urgently and the need to go excessively at night. Lilly said many
men who have erectile dysfunction also experience the symptoms of an
Last month, the European Union's Committee for
Medicinal Products for Human Use recommended the approval of Cialis for
the expanded use.
The U.S. Food and Drug Administration approved the expanded use last fall.
brought in $1.88 billion last year, or 8% of Lilly's total revenue, as
its fifth-best-selling product. It recorded $1.41 billion in revenue
through the first three quarters of 2012.
Company shares did not trade Tuesday because all exchanges are closed due to Hurricane Sandy.